Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 21, 2002

View Archived Issues

Zonagen and Lavipharm merge in a tax-free, stock-for-stock transaction

Biovation and Micromet expand collaboration

Novartis to evaluate cardiovascular outcome benefits of Lotrel in new trial

BresaGen acquires patent rights in stem cell technology

Once-daily tomoxetine reported effective in ADHD

Beneficial effects reported for recombinant human GAA in infantile Pompe's disease

New data on ranolazine in chronic angina: the CARISA study

Raloxifene in women with increased cardiovascular risk

E.U. approval for Somavert

Ocinaplon reported effective and safer than benzodiazepines in GAD

Aciphex combination treatment approved for seven-day eradication of H. pylori

Studies show NGD-971 to be ineffective in Alzheimer's patients

Pharmacia updates Bextra label with new warnings

Roche to acquire promising portfolio of cancer drugs from Antisoma

BioPartners to use Durect technology to produce sustained-release interferon alfa

Urea-based VR1 antagonists as potential analgesic agents

Series of PDE5 inhibitors identified by Pfizer researchers

Compounds with 5-HT reuptake-inhibitory/5-HT1A receptor-antagonist activity discovered at Wyeth

New antithrombotic compounds under study at Boehringer Ingelheim

Gruenenthal and U. of Leiden describe new modulators of NMDA and adenosine metabolism

Novel p38 inhibitors synthesized by Pfizer scientists

Aventis scientists present new tubulin polymerization inhibitors

Cel-Sci enters agreement with Proxima Concepts for development of oral CEL-1000

THP and SangStat collaborate on development of humanized polyclonal antibody drugs

Antitumor activity and resistance mechanisms further characterized for XR-5944 and XR-11576

Phase I data for NB-1011 discussed at EORTC-NCI-AACR symposium

Oxi-4503 compares favorably to CA4P in antivascular and antitumor activity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...